• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样蛋白-β的抗纤维化作用及其在肝硬化中的缺失。

Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver.

机构信息

Department of Clinical Pharmacology, University Hospital of Tübingen, 72076 Tübingen, Germany.

H. Buniatian Institute of Biochemistry, National Academy of Sciences of the Republic of Armenia (NAS RA), Yerevan 0014, Armenia.

出版信息

Cells. 2020 Feb 17;9(2):452. doi: 10.3390/cells9020452.

DOI:10.3390/cells9020452
PMID:32089540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7072823/
Abstract

The function and regulation of amyloid-beta (Aβ) in healthy and diseased liver remains unexplored. Because Aβ reduces the integrity of the blood-brain barrier we have examined its potential role in regulating the sinusoidal permeability of normal and cirrhotic liver. Aβ and key proteins that generate (beta-secretase 1 and presenilin-1) and degrade it (neprilysin and myelin basic protein) were decreased in human cirrhotic liver. In culture, activated hepatic stellate cells (HSC) internalized Aβ more efficiently than astrocytes and HSC degraded Aβ leading to suppressed expression of α-smooth muscle actin (α-SMA), collagen 1 and transforming growth factor β (TGFβ). Aβ also upregulated sinusoidal permeability marker endothelial NO synthase (eNOS) and decreased TGFβ in cultured human liver sinusoidal endothelial cells (hLSEC). Liver Aβ levels also correlate with the expression of eNOS in transgenic Alzheimer's disease mice and in human and rodent cirrhosis/fibrosis. These findings suggest a previously unexplored role of Aβ in the maintenance of liver sinusoidal permeability and in protection against cirrhosis/fibrosis via attenuation of HSC activation.

摘要

淀粉样蛋白-β(Aβ)在健康和患病肝脏中的功能和调节作用仍未被探索。由于 Aβ 降低了血脑屏障的完整性,我们研究了它在调节正常和肝硬化肝脏窦状隙通透性中的潜在作用。在人类肝硬化肝脏中,Aβ 及其产生的关键蛋白(β-分泌酶 1 和早老素 1)和降解它的蛋白(神经肽酶和髓鞘碱性蛋白)减少了。在培养中,活化的肝星状细胞(HSC)比星形胶质细胞更有效地内化 Aβ,并且 HSC 降解 Aβ,导致α-平滑肌肌动蛋白(α-SMA)、胶原 1 和转化生长因子β(TGFβ)的表达受到抑制。Aβ 还在上皮型一氧化氮合酶(eNOS)上调窦状隙通透性标志物,并降低培养的人肝窦内皮细胞(hLSEC)中的 TGFβ。肝 Aβ 水平也与转阿尔茨海默病小鼠以及人和啮齿动物肝硬化/纤维化中 eNOS 的表达相关。这些发现提示了 Aβ 在维持肝窦状隙通透性以及通过抑制 HSC 活化来防止肝硬化/纤维化方面的一个以前未被探索的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/3fc2cd6b6f15/cells-09-00452-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/d26f56598444/cells-09-00452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/05d521d18b95/cells-09-00452-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/659546130f0c/cells-09-00452-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/10298fa9639f/cells-09-00452-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/351507660253/cells-09-00452-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/2a4ddbb56ffc/cells-09-00452-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/e3a65f3bcd1c/cells-09-00452-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/a7ba9022f97b/cells-09-00452-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/3fc2cd6b6f15/cells-09-00452-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/d26f56598444/cells-09-00452-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/05d521d18b95/cells-09-00452-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/659546130f0c/cells-09-00452-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/10298fa9639f/cells-09-00452-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/351507660253/cells-09-00452-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/2a4ddbb56ffc/cells-09-00452-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/e3a65f3bcd1c/cells-09-00452-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/a7ba9022f97b/cells-09-00452-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11e3/7072823/3fc2cd6b6f15/cells-09-00452-g009.jpg

相似文献

1
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver.淀粉样蛋白-β的抗纤维化作用及其在肝硬化中的缺失。
Cells. 2020 Feb 17;9(2):452. doi: 10.3390/cells9020452.
2
Consequences of Amyloid-β Deficiency for the Liver.淀粉样蛋白-β缺乏对肝脏的影响。
Adv Sci (Weinh). 2024 May;11(18):e2307734. doi: 10.1002/advs.202307734. Epub 2024 Mar 2.
3
Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.替罗非班,一种 TP 受体拮抗剂,可降低肝硬化大鼠的门静脉压力。
Hepatology. 2013 Oct;58(4):1424-35. doi: 10.1002/hep.26520. Epub 2013 Aug 7.
4
Cooperation of liver cells in health and disease.健康与疾病状态下肝细胞的协作。
Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3.
5
Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis.辛伐他汀通过调节非酒精性脂肪性肝炎相关肝纤维化大鼠的一氧化氮合酶改善肝纤维化。
PLoS One. 2013 Oct 2;8(10):e76538. doi: 10.1371/journal.pone.0076538. eCollection 2013.
6
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.FXR 激动剂 PX20606 通过靶向血管重塑和窦状隙功能障碍改善门脉高压。
J Hepatol. 2017 Apr;66(4):724-733. doi: 10.1016/j.jhep.2016.12.005. Epub 2016 Dec 18.
7
Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP.β淀粉样前体蛋白(βAPP)和淀粉样前体样蛋白(APLP)的细胞内结构域对β淀粉样蛋白降解酶中性内肽酶的早老素依赖性转录调控
Neuron. 2005 May 19;46(4):541-54. doi: 10.1016/j.neuron.2005.04.008.
8
Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl-induced cirrhotic rats.尾加压素 II 受体拮抗剂通过增强 CCl4 诱导的肝硬化大鼠中内皮型一氧化氮合酶依赖性 HSC 血管舒张作用降低肝阻力和门脉压。
Front Med. 2019 Jun;13(3):398-408. doi: 10.1007/s11684-019-0689-5. Epub 2019 Jun 11.
9
Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.β淀粉样肽激活培养的星形胶质细胞:形态学改变、细胞因子诱导及一氧化氮释放。
Brain Res. 1998 Mar 2;785(2):195-206. doi: 10.1016/s0006-8993(97)01318-8.
10
[Mechanism of Qijia Rougan Decoction and its disassembled formulas on regulation of VEGF/SRF/c-FOS pathway and improvement of hepatic sinusoidal capillaryization in rats with hepatic fibrosis].
Zhongguo Zhong Yao Za Zhi. 2024 Oct;49(20):5528-5538. doi: 10.19540/j.cnki.cjcmm.20240710.401.

引用本文的文献

1
Therapeutic Potential of Ellagic Acid in Liver Diseases.鞣花酸在肝脏疾病中的治疗潜力
Molecules. 2025 Jun 15;30(12):2596. doi: 10.3390/molecules30122596.
2
Hepatocyte Apolipoprotein J Accelerates Injury-induced Liver Fibrosis by Activation Signal Transducer and Activator of Transcription 3 Through Ranbp2 Mediated-SUMOylation.肝细胞载脂蛋白J通过Ranbp2介导的SUMO化激活信号转导子和转录激活子3加速损伤诱导的肝纤维化。
Cell Mol Gastroenterol Hepatol. 2025 Jun 20:101556. doi: 10.1016/j.jcmgh.2025.101556.
3
Hepatic Amyloid Beta-42-Metabolizing Proteins in Liver Steatosis and Metabolic Dysfunction-Associated Steatohepatitis.

本文引用的文献

1
Isolation and Culture of Primary Murine Hepatic Stellate Cells.原代小鼠肝星状细胞的分离与培养
Methods Mol Biol. 2017;1627:165-191. doi: 10.1007/978-1-4939-7113-8_11.
2
A positive feedback loop between nitric oxide and amyloid β (1-42) accelerates mitochondrial damage in human lens epithelial cells.一氧化氮与淀粉样β蛋白(1-42)之间的正反馈回路加速了人晶状体上皮细胞中的线粒体损伤。
Toxicology. 2017 Apr 15;381:19-30. doi: 10.1016/j.tox.2017.02.014. Epub 2017 Feb 24.
3
Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels-Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance.
肝脏脂肪变性和代谢相关脂肪性肝炎中的肝β淀粉样蛋白 42 代谢蛋白。
Int J Mol Sci. 2024 Aug 12;25(16):8768. doi: 10.3390/ijms25168768.
4
Does amyloid β precursor protein gene expression have a role in diagnosis of biliary atresia?淀粉样前体蛋白基因表达在胆道闭锁的诊断中有作用吗?
Clin Exp Hepatol. 2023 Dec;9(4):335-343. doi: 10.5114/ceh.2023.132818. Epub 2023 Nov 14.
5
Consequences of Amyloid-β Deficiency for the Liver.淀粉样蛋白-β缺乏对肝脏的影响。
Adv Sci (Weinh). 2024 May;11(18):e2307734. doi: 10.1002/advs.202307734. Epub 2024 Mar 2.
6
Ferroptosis-Related Genes with Regard to CTLA-4 and Immune Infiltration in Hepatocellular Carcinoma.
Biochem Genet. 2023 Apr;61(2):687-703. doi: 10.1007/s10528-022-10279-4. Epub 2022 Sep 12.
7
Serum Amyloid Beta42 Is Not Eliminated by the Cirrhotic Liver: A Pilot Study.血清淀粉样蛋白β42不能被肝硬化肝脏清除:一项初步研究。
J Clin Med. 2021 Jun 17;10(12):2669. doi: 10.3390/jcm10122669.
8
Losartan Improves Memory, Neurogenesis and Cell Motility in Transgenic Alzheimer's Mice.氯沙坦可改善转基因阿尔茨海默病小鼠的记忆、神经发生和细胞运动能力。
Pharmaceuticals (Basel). 2021 Feb 20;14(2):166. doi: 10.3390/ph14020166.
9
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis".专题:“肝纤维化发病机制的细胞和分子机制”
Cells. 2020 Apr 29;9(5):1105. doi: 10.3390/cells9051105.
肝功能与血浆β淀粉样蛋白水平之间的关联——对肝脏在外周β淀粉样蛋白清除能力方面的启示
Mol Neurobiol. 2017 Apr;54(3):2338-2344. doi: 10.1007/s12035-016-9826-1. Epub 2016 Mar 9.
4
Age-dependent inverse correlations in CSF and plasma amyloid-β(1-42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice.在3xTg-AD小鼠大脑中淀粉样斑块沉积之前,脑脊液和血浆中淀粉样β蛋白(1-42)浓度与年龄呈负相关。
Sci Rep. 2016 Feb 2;6:20185. doi: 10.1038/srep20185.
5
Developing therapeutic vaccines against Alzheimer's disease.研发针对阿尔茨海默病的治疗性疫苗。
Expert Rev Vaccines. 2016;15(3):401-15. doi: 10.1586/14760584.2016.1121815. Epub 2015 Dec 11.
6
Uncoupling of endothelial nitric oxide synthase in cerebral vasculature of Tg2576 mice.Tg2576小鼠脑血管中内皮型一氧化氮合酶的解偶联
J Neurochem. 2015 Sep;134(6):1129-38. doi: 10.1111/jnc.13205. Epub 2015 Jul 15.
7
Induction of experimental obstructive cholestasis in mice.在小鼠中诱导实验性梗阻性胆汁淤积。
Lab Anim. 2015 Apr;49(1 Suppl):70-80. doi: 10.1177/0023677214567748.
8
Interferon-Gamma Increases Endothelial Permeability by Causing Activation of p38 MAP Kinase and Actin Cytoskeleton Alteration.γ-干扰素通过激活p38丝裂原活化蛋白激酶并改变肌动蛋白细胞骨架来增加内皮通透性。
J Interferon Cytokine Res. 2015 Jul;35(7):513-22. doi: 10.1089/jir.2014.0188. Epub 2015 Apr 1.
9
Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis.小鼠胆管结扎:梗阻性胆汁淤积诱导炎症性肝损伤和肝纤维化
J Vis Exp. 2015 Feb 10(96):52438. doi: 10.3791/52438.
10
The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension.利用纳米颗粒向肝星状细胞递送一氧化氮以治疗肝纤维化和门静脉高压。
Small. 2015 May 20;11(19):2291-304. doi: 10.1002/smll.201402870. Epub 2015 Jan 13.